Citation 7105

LIN,CC: HSU,YF: LIN,TC:. (2001). ANTIOXIDANT AND FREE RADICAL SCAVENGING EFFECTS OF THE TANNINS OF TERMINALIA CATAPPA L.. 21(243)

Citation Details

Title	ANTIOXIDANT AND FREE RADICAL SCAVENGING EFFECTS OF THE TANNINS OF TERMINALIA CATAPPA L.
Authors	LIN,CC: HSU,YF: LIN,TC:
Year	2001
Volume	21
Issue	243

Summary

Year: 2001

Journal: Unknown

Organisms and Their Experiments (1)

Terminalia catappa (COMBRETACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OF	CHEBULAGIC ACID	None
2	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHEBULAGIC ACID	WEAK ACTIVITY
3	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHEBULAGIC ACID	WEAK ACTIVITY
4	CYTOCHROME C REDUCTION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CHEBULAGIC ACID	ACTIVE
5	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	CHEBULAGIC ACID	ACTIVE
6	Not specified	ISOLATION AND IDENTIFICATION OF	GERANIIN	None
7	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GERANIIN	WEAK ACTIVITY
8	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GERANIIN	WEAK ACTIVITY
9	CYTOCHROME C REDUCTION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	GERANIIN	ACTIVE
10	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	GERANIIN	ACTIVE
11	Not specified	ISOLATION AND IDENTIFICATION OF	PUNICALAGIN	None
12	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PUNICALAGIN	WEAK ACTIVITY
13	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PUNICALAGIN	WEAK ACTIVITY
14	CYTOCHROME C REDUCTION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	PUNICALAGIN	ACTIVE
15	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	PUNICALAGIN	ACTIVE
16	Not specified	ISOLATION AND IDENTIFICATION OF	PUNICALIN	None
17	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PUNICALIN	WEAK ACTIVITY
18	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PUNICALIN	WEAK ACTIVITY
19	CYTOCHROME C REDUCTION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	PUNICALIN	ACTIVE
20	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	PUNICALIN	ACTIVE
21	Not specified	ISOLATION AND IDENTIFICATION OF	EUGENIIN,1-DEGALLOYL:	None
22	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUGENIIN,1-DEGALLOYL:	ACTIVE
23	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUGENIIN,1-DEGALLOYL:	WEAK ACTIVITY
24	CYTOCHROME C REDUCTION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	EUGENIIN,1-DEGALLOYL:	ACTIVE
25	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	EUGENIIN,1-DEGALLOYL:	ACTIVE
26	Not specified	ISOLATION AND IDENTIFICATION OF	CORILAGIN	None
27	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORILAGIN	WEAK ACTIVITY
28	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORILAGIN	EQUIVOCAL
29	CYTOCHROME C REDUCTION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CORILAGIN	ACTIVE
30	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	CORILAGIN	ACTIVE
31	Not specified	ISOLATION AND IDENTIFICATION OF	TERCATAIN	None
32	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TERCATAIN	ACTIVE
33	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TERCATAIN	WEAK ACTIVITY
34	CYTOCHROME C REDUCTION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	TERCATAIN	ACTIVE
35	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	TERCATAIN	ACTIVE
36	Not specified	ISOLATION AND IDENTIFICATION OF	GALLIC ACID	None
37	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLIC ACID	WEAK ACTIVITY
38	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLIC ACID	EQUIVOCAL
39	CYTOCHROME C REDUCTION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLIC ACID	ACTIVE
40	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLIC ACID	ACTIVE
41	Not specified	ISOLATION AND IDENTIFICATION OF	ELLAGIC ACID	None
42	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ELLAGIC ACID	EQUIVOCAL
43	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ELLAGIC ACID	WEAK ACTIVITY
44	CYTOCHROME C REDUCTION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	ELLAGIC ACID	ACTIVE
45	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	ELLAGIC ACID	WEAK ACTIVITY

Citation 7105

Citation Details

Summary

Organisms and Their Experiments (1)

Terminalia catappa (COMBRETACEAE)

Show SPARQL Queries (1)

Query 1